Contents
Aducanumab: The New Frontier in Alzheimer's Treatment?
Published: Aug 24, 2024
Explore the controversial approval of Aducanumab and its potential impact on Alzheimer's treatment.
What is Aducanumab?
Aducanumab is a monoclonal antibody that targets amyloid beta plaques in the brain, thought to be a hallmark of Alzheimer's. It was granted accelerated approval by the FDA based on its ability to reduce these plaques. However, its effectiveness in improving clinical outcomes remains uncertain, sparking debate among experts.
Who Might Benefit?
The drug is currently considered for patients with early-stage Alzheimer's who have confirmed amyloid pathology. Its use is limited to those without contraindications like non-Alzheimer's dementia or high hemorrhagic risk. Patient selection should be thorough, involving cognitive and laboratory testing.
Risks and Monitoring
Aducanumab treatment comes with risks, including amyloid-related imaging abnormalities (ARIA), which occur in about 40% of patients. Monitoring involves regular brain MRIs to detect these abnormalities. The decision to use Aducanumab involves weighing potential benefits against these known risks.
Frequently Asked Questions
It's used to target amyloid beta plaques in early Alzheimer's.
Patients with early-stage Alzheimer's and confirmed amyloid pathology.
Yes, it can cause amyloid-related imaging abnormalities (ARIA).
Its effectiveness in clinical outcomes is still uncertain.
Key Takeaways
Aducanumab's approval marks a new chapter in Alzheimer's treatment, but its real-world impact remains to be seen.
References
- FDA Grants Accelerated Approval for Alzheimer’s Drug. US Food and Drug Administration.
- Rabinovici GD. Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab. N Engl J Med 2021; 385:771.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?